Study design, materials and methods
This descriptive study was conducted from August 11, 2023, to February 11, 2024. A total of 127 male patients aged over 40 years with prostate sizes between 40-80 grams on ultrasonography were included. Exclusion criteria included patients with a history of prostate cancer or prior prostate surgery. TURP was performed on all patients using a bipolar resectoscope under spinal anesthesia. Postoperative complications such as urinary tract infections (UTIs), hematuria, lower urinary tract symptoms (LUTS), recatheterization, and hospital stay duration were assessed. Statistical analysis was performed using IBM SPSS Version 23, and chi-square and independent t-tests were used to compare the AUR and non-AUR groups. Statistical significance was defined as p ≤ 0.05.
Results
The mean age of patients was 64.92 ± 3.8 years. AUR was observed in 63 patients (49.6%). Postoperative complications, including UTIs (17.5% vs. 14.1%, p=0.39), hematuria (12.7% vs. 25.0%, p=0.06), LUTS (12.7% vs. 7.8%, p=0.27), recatheterization (22.2% vs. 23.4%, p=0.52), and sepsis (15.9% vs. 9.4%, p=0.20), were more frequent in the AUR group, though the differences were not statistically significant. The need for blood transfusions was higher in the AUR group (28.6% vs. 17.2%, p=0.09). Hospital stay duration and symptom resolution rates were similar between the groups.
Interpretation of results
Patients with AUR had higher rates of certain postoperative complications, including UTIs, hematuria, and blood transfusions. However, these differences did not reach statistical significance. The length of hospital stay and symptom resolution were comparable between the two groups, suggesting that while AUR may increase the risk of some complications, it does not significantly impact overall recovery.